From: HIV diagnosis period influences ART initiation: findings from a prospective cohort study in China
 | All n (%) | Diagnosed before implementing the new strategy n (%) | Diagnosed after implementing the new strategy n (%) | P |
---|---|---|---|---|
Socio-demographic characteristics | ||||
 Gender | 0.024 | |||
  Male | 389 (94.6) | 137 (91.3) | 252 (96.6) |  |
  Female | 22 (5.4) | 13 (8.7) | 9 (3.4) |  |
 Age (years, mean ± s.d) | 32.8 ± 10.6 | 32.7 ± 9.8 | 32.9 ± 11.1 | 0.600 |
 Age (years) | 0.603 | |||
  ≤ 25 | 106 (25.8) | 35 (23.3) | 71 (27.2) |  |
  25–35 | 172 (41.8) | 67 (44.7) | 105 (40.2) |  |
  > 35 | 133 (32.4) | 48 (32.0) | 85 (32.6) |  |
 Ethnicity | 0.003 | |||
  Han | 384 (93.4) | 133 (88.7) | 251 (96.2) |  |
  Other | 27 (6.6) | 17 (11.3) | 10 (3.8) |  |
 Education | 0.031 | |||
  Junior high school and below | 113 (27.5) | 50 (33.3) | 63 (24.1) |  |
  Secondary school | 128 (31.1) | 50 (33.3) | 78 (29.9) |  |
  College or above | 170 (41.4) | 50 (33.3) | 120 (46.0) |  |
 Monthly income (RMB) | 0.522 | |||
  ≤ 3000 (434 USD) | 154 (37.7) | 55 (37.2) | 99 (38.1) |  |
  3000–5000 (434–723 USD) | 144 (35.3) | 57 (38.5) | 87 (33.5) |  |
  > 5000 (723 USD) | 110 (27.0) | 36 (24.3) | 74 (28.5) |  |
 Current marital status | 0.384 | |||
  Single | 255 (62.0) | 99 (66.0) | 156 (59.8) |  |
  Married/cohabitation | 103 (25.1) | 32 (21.3) | 71 (27.2) |  |
  Separated/divorced/other | 53 (12.9) | 19 (12.7) | 34 (13.0) |  |
 Household registration | 0.304 | |||
  Guangzhou | 94 (22.9) | 28 (18.8) | 66 (25.3) |  |
  Other cities of Guangdong Province | 116 (28.3) | 43 (28.9) | 73 (28.0) |  |
  Other province | 200 (48.8) | 78 (52.3) | 122 (46.7) |  |
 Residential district | 0.384 | |||
  Urban | 288 (70.1) | 109 (72.7) | 179 (68.6) |  |
  Suburb | 123 (29.9) | 41 (27.3) | 82 (31.4) |  |
HIV infection-related conditions | ||||
 Route of HIV infection | 0.035 | |||
  Heterosexual | 89 (21.7) | 39 (26.2) | 50 (19.2) |  |
  Homosexual | 301 (73.2) | 99 (66.4) | 202 (77.4) |  |
  Others (unknown, injecting drug use) | 20 (4.9) | 11 (7.4) | 9 (3.4) |  |
 Latest CD4 cell counts | < 0.001 | |||
  ≤ 350 | 226 (55.0) | 54 (36.0) | 172 (65.9) |  |
  350–500 | 121 (29.4) | 60 (40.0) | 61 (23.4) |  |
  > 500 | 64 (15.6) | 36 (24.0) | 28 (10.7) |  |
 Self-reported health status | 0.182 | |||
  Very good/good | 168 (40.9) | 70 (46.7) | 98 (37.5) |  |
  Not good or poor | 213 (51.8) | 71 (47.3) | 142 (54.4) |  |
  Poor/very poor | 30 (7.3) | 9 (6.0) | 21 (8.0) |  |
HBM-related ART perceptions (mean ± s.d) | ||||
 Perceived severity | 4.1 ± 0.7 | 3.9 ± 0.7 | 4.2 ± 0.7 | < 0.001 |
 Perceived susceptibility | 4.3 ± 0.8 | 4.1 ± 0.8 | 4.3 ± 0.8 | 0.001 |
 Perceived benefits | 4.2 ± 0.6 | 4.1 ± 0.7 | 4.2 ± 0.6 | 0.012 |
 Perceived barriers | 3.1 ± 0.7 | 3.2 ± 0.7 | 3.1 ± 0.7 | 0.028 |
 Self-efficacy | 4.2 ± 0.8 | 4.0 ± 0.9 | 4.4 ± 0.6 | < 0.001 |